The reported operating result (EBIT) of the Consumer Health division increased by around € 54 million to € 62 million (2012: € 8 million) and EBITDA more than doubled, climbing to € 71 million (2012: € 30 million). Adjusted for one-time items, EBITDA pre one-time items rose by 8.5% to € 72 million, or 15.2% of sales (2012: € 67 million or 14.1% of sales).
The implementation of the measures initiated as part of the “Fit for 2018” transformation and growth program as well as better resource allocation improved the division’s cost structure, leading to a visible increase in profitability and the aforementioned organic top-line growth. In particular, the division’s strategic brands, which benefited most from more focused investment in marketing, sales and R&D activities, showed a strong improvement in this respect.
Structural adaptations, for example changes to the product portfolio and the exit from unprofitable markets, also resulted in a more profitable base for the division’s business. Consumer Health thus established a good foundation and achieved a high profitability level, which should form a solid starting base for developments in the coming years.
| XLS |
|
Consumer Health | Reconciliation EBIT to EBITDA pre one-time items |
|||
|
|
|
|
|
|
|
|
|
|
|
€ million |
2013 |
2012 |
Change in % |
|
Operating result (EBIT) |
62.2 |
7.6 |
– |
|
Depreciation/Amortization/Reversals of impairments |
8.9 |
22.2 |
–59.9 |
|
EBITDA |
71.1 |
29.8 |
138.6 |
|
One-time items |
1.4 |
37.0 |
–96.2 |
|
EBITDA pre one-time items |
72.5 |
66.8 |
8.5 |
The development of EBITDA pre one-time items in the individual quarters in comparison with 2012 is presented in the following table:
Consumer Health | EBITDA pre one-time items and change by quarter 1
